Curriculum Vitae

Download as PDF

Adam Sacarny
Department of Health Policy & Management
Columbia University Mailman School of Public Health
722 West 168 Street, 4th Floor
New York, NY 10032

Employment

2016-PresentAssistant Professor of Health Policy and Management, Columbia University Mailman School of Public Health
2014-2015Robert Wood Johnson Scholar in Health Policy Research, Harvard University

Other Affiliations

2016-PresentFaculty Research Fellow, National Bureau of Economic Research
2016-PresentAffiliate, Abdul Latif Jameel Poverty Action Lab (J-PAL)
2017-PresentAcademic Affiliate, Office of Evaluation Sciences, U.S. General Services Administration
2017-PresentAffiliate, Columbia Population Research Center (CPRC)

Education

2009-2014PhD, Economics, Massachusetts Institute of Technology
2003-2007BA, Economics, Columbia University

Publications

Sachs, Rachel E. and Adam Sacarny. 2020. “Ensuring Access to Emerging COVID-19 Treatments Through Medicare Reimbursement Policy.” JAMA Health Forum, August 7.
Sacarny, Adam, Andrew Olenski, and Michael L. Barnett. 2019. “Association of Quetiapine Overuse Letters With Prescribing by Physician Peers of Targeted Recipients: A Secondary Analysis of a Randomized Clinical Trial.” JAMA Psychiatry, 76(10): 1094-1095.
Sacarny, Adam, Michael L. Barnett, and Shantanu Agrawal. 2019. “New Evidence on Stemming Low-Value Prescribing.” NEJM Catalyst, April 10.
Sacarny, Adam, Michael L. Barnett, Jackson Le, Frank Tetkoski, David Yokum, and Shantanu Agrawal. 2018. “Peer Comparison Letters for High Volume Primary Care Prescribers of Quetiapine in Older and Disabled Adults: A Randomized Clinical Trial.” JAMA Psychiatry, 75(10): 1003-1011.
Glied, Sherry and Adam Sacarny. 2018. “Is the U.S. Healthcare System Wasteful and Inefficient? A Review of the Evidence.” Journal of Health Politics, Policy and Law, 43(5): 739-765.
Sacarny, Adam. 2018. “Adoption and Learning Across Hospitals: The Case of a Revenue-Generating Practice.” Journal of Health Economics, 60: 142-164.
Sacarny, Adam, David Yokum, and Shantanu Agrawal. 2017. “Government-Academic Partnerships in Randomized Evaluations: The Case of Inappropriate Prescribing.” American Economic Review Papers & Proceedings, 107(5): 466-470.
Marzilli Ericson, Keith M., Jon Kingsdale, Timothy Layton, and Adam Sacarny. 2017. “Nudging Leads Consumers In Colorado To Shop But Not Switch ACA Marketplace Plans.” Health Affairs, 36(2): 311-319.
Chandra, Amitabh, Amy Finkelstein, Adam Sacarny, and Chad Syverson. 2016. “Perhaps Market Forces Do Work in Health Care After All.” Harvard Business Review (Online), December.
Chandra, Amitabh, Amy Finkelstein, Adam Sacarny, and Chad Syverson. 2016. “Healthcare Exceptionalism? Performance and Allocation in the U.S. Healthcare Sector.” American Economic Review, 106(8): 2110-2144.
Chandra, Amitabh, Amy Finkelstein, Adam Sacarny, and Chad Syverson. 2016. “Productivity Dispersion in Medicine and Manufacturing.” American Economic Review Papers & Proceedings, 106(5): 99-103.
Sacarny, Adam, David Yokum, Amy Finkelstein, and Shantanu Agrawal. 2016. “Medicare Letters To Curb Overprescribing Of Controlled Substances Had No Detectable Effect On Providers.” Health Affairs, 35(3): 471-479.

Working Papers

Chandra, Amitabh, Pragya Kakani, and Adam Sacarny. 2020. “Hospital Allocation and Racial Disparities in Health Care” NBER Working Paper No. 28018.
Barnett, Michael, Andrew Olenski, and Adam Sacarny. 2020. “Common Practice: Spillovers from Medicare on Private Health Care.” NBER Working Paper No. 27270 (revisions requested at American Economic Journal: Economic Policy)
Sacarny, Adam, Katherine Baicker, and Amy Finkelstein. 2020. “Out of the Woodwork: Enrollment Spillovers in the Oregon Health Insurance Experiment.” NBER Working Paper No. 26871 (conditionally accepted at American Economic Journal: Economic Policy)
Chandra, Amitabh, Amy Finkelstein, Adam Sacarny, and Chad Syverson. 2013. “Healthcare Exceptionalism? Productivity and Allocation in the U.S. Healthcare Sector.” NBER Working Paper No. 19200

Randomized Trials in Progress

“Nudging Providers to Curtail Dangerous Opioid Prescribing: A Trial to Investigate Mechanisms” (with Tatyana Avilova, Mireille Jacobson, Weston Merrick, David Powell, and Ian Williamson; enrollment complete)
“The Effect of Behavioral Interventions on Enrollment and Adverse Selection in Health Insurance Marketplaces” (with Timothy Layton, Keith M. Marzilli Ericson, and Adrianna McIntyre; enrollment complete)
“Reducing Concurrent Opioid-Benzodiazepine Prescriptions Through Provider Intervention” (with Elana Safran and Mary Steffel; enrollment complete)

Other Research in Progress

“Inequities in COVID-19 Vaccination in Major U.S. Cities” (with Jamie Daw)
“Technology Adoption and Market Allocation: The Case of Robotic Surgery” (with Danea Horn and Annetta Zhou)
“The Anatomy of a Hospital System Merger: The Patient Did Not Respond Well to Treatment” (with Martin Gaynor, Raffaella Sadun, Chad Syverson, and Shruthi Venkatesh)
“Regulated Revenues and Hospital Behavior: Evidence from a Medicare Overhaul” (with Tal Gross, Maggie Shi, and David Silver)
“Fragmentation of Care and the Quality of Opioid and Benzodiazepine Prescribing for Older Adults” (with Keith M. Marzilli Ericson and Annetta Zhou)

Honors and Awards

2019AcademyHealth Publication of the Year (``Effect of Peer Comparison Letters for High-Volume Primary Care Prescribers of Quetiapine in Older and Disabled Adults: A Randomized Clinical Trial'')
2019NIHCM Health Care Research Award Finalist (``Effect of Peer Comparison Letters for High-Volume Primary Care Prescribers of Quetiapine in Older and Disabled Adults: A Randomized Clinical Trial'')
2007Phi Beta Kappa

Grants and Fellowships

2021-2022National Institute for Health Care Management - Nudging Providers to Curtail Dangerous Opioid Prescribing and Improve the Safety of the Health Care Delivery System (PI: Adam Sacarny), $50,000
2021-2022National Institute on Aging (R21AG070942) - The Effect of De-Prescribing Antipsychotics on Health and Quality of Life for People with Dementia (PI: Adam Sacarny), $427,914
2020-2022J-PAL North America - Nudging Providers to Curtail Dangerous Opioid Prescribing: A Trial to Investigate Mechanisms (PI: Adam Sacarny), $142,579
2017-2022National Institute on Aging (P01AG005842) - Improving Health Outcomes for an Aging Population, Project: Market Learning and Health Care Disparities (PLs: Amitabh Chandra and Adam Sacarny, PI: Katherine Baicker), $156,676/year
2017-2022National Institute on Aging (R01AG034151) - What Does Health Insurance Do? Evidence from the Oregon Health Insurance Lottery (PIs: Katherine Baicker and Amy Finkelstein), $561,546/year
2018-2020J-PAL North America - The Effect of Behavioral Interventions on Enrollment and Adverse Selection in Health Insurance Marketplaces (PI: Timothy Layton), $206,010
2016-2020Laura and John Arnold Foundation – Using HCCI Data to Study Issues Relating to the Efficiency of the US Health Care System (PI: Amy Finkelstein), $475,000
2019National Institute on Aging (P01AG005842) - Improving Health Outcomes for an Aging Population, Project: How Health Insurance Affects Health (PLs: Katherine Baicker and Amy Finkelstein), $155,082/year
2015-2017J-PAL North America – Intervening with Consumers to Improve Choices on Health Insurance Marketplaces (PIs: Adam Sacarny and Katherine Swartz), $135,300
2014-2017J-PAL North America – Reducing Inappropriate Prescribing of Controlled Substances in the United States (PI: Adam Sacarny), $7,082
2012-2014NBER Health and Aging Pre-Doctoral Fellowship
2012George and Obie Shultz Research Support Grant
2009-2011John Castle Graduate International Fellowship

Seminars and Talks

2021MIT Sloan Organizational Economics Lunch Series; American Society of Health Economists Meeting (Online Presentation)
2020American Economic Association Meetings (San Diego, CA); Agency for Healthcare Research and Quality; Children's Hospital of Philadelphia PolicyLab; Junior Health Economics Summit (Whistler, BC); NBER Summer Institute (Online Presentation); University of Pennsylvania Center for Clinical Epidemiology and Biostatistics
2019Junior Health Economics Summit (Whistler, BC); Dartmouth NIA/P01 Research Meeting (Boston, MA); Hunter College; AcademyHealth Research Meeting (Washington, DC) CEPRA/NBER Workshop on Aging and Health (Lugano, Switzerland); American Society of Health Economists Meeting (Washington, DC); iHEA World Congress (Basel, Switzerland); New York Academy of Medicine; Princeton University; Office of Evaluation Sciences “Using Evidence” Meeting (Washington, DC)
2018American Economic Association Meetings (Philadelphia, PA); University of Minnesota School of Public Health; University of Pennsylvania; Junior Health Economics Summit (Whistler, BC); American University; American Society of Health Economists Meeting (Atlanta, GA)
2017American Economic Association Meetings (Chicago, IL); AcademyHealth National Health Policy Conference (Washington, DC); Junior Health Economics Summit (Whistler, BC); University at Albany – SUNY; Challenging the Conventional Wisdom Conference (Columbia University); iHEA World Congress (Boston, MA); Advances with Field Experiments Conference (Chicago, IL); Cornell University
2016Junior Health Economics Summit (Whistler, BC); Vanderbilt University; Robert Wood Johnson Foundation Scholars in Health Policy Research Annual Meeting (Aspen, CO); American Society of Health Economists Meeting (Philadelphia, PA); AcademyHealth Research Meeting (Boston, MA); Advances with Field Experiments Conference (Chicago, IL); RAND (Santa Monica, CA); Office of Evaluation Sciences (Washington, DC); APPAM Fall Research Conference (Washington, DC); Hunter College; J-PAL North America Conference (Cambridge, MA); Public-Academic Research Colloquium (Washington, DC)
2015Harvard Medical School; White House Social and Behavioral Sciences Team; Robert Wood Johnson Foundation Scholars in Health Policy Research Annual Meeting (San Diego, CA); iHEA World Congress (Milan, Italy); University of Chicago School of Social Service Administration; University of Chicago Harris School of Public Policy Studies
2014Columbia University Mailman School of Public Health; Congressional Budget Office; Stanford University School of Medicine; Yale School of Public Health; University of Minnesota School of Public Health; Johns Hopkins Carey Business School; USC Price School of Public Policy; Federal Reserve Bank of New York

Discussant

2021American Society of Health Economists Meeting (Online)
2020American Economic Association Meetings (San Diego, CA)
2019Japan Economic Seminar (New York, NY)
2018American Society of Health Economists Meeting (Atlanta, GA)
2016American Society of Health Economists Meeting (Philadelphia, PA); Annual Health Economics Conference (Nashville, TN); National Tax Association Meetings (Baltimore, MD)
2015National Tax Association Annual Conference on Taxation (Boston, MA)

Teaching

2016-PresentResearch Methods III: Analysis of Large Scale Data (P8508)
2016-2018Research Methods I: Empirical Analysis for Health Policy (P8502)

Previous Relevant Positions

2009-2014Research Assistant, Professor Amy Finkelstein
2008-2009Associate Economist, Federal Reserve Bank of New York
2007-2008Research Associate, Federal Reserve Bank of New York

Professional Activities

Referee for: American Economic Journal: Applied Economics, American Economic Journal: Economic Policy, American Economic Review, American Economic Review: Insights, American Journal of Health Economics, BMJ, Economic Journal, Health Affairs, Health Economics, Health Services Research, INQUIRY, J-PAL North America State and Local Innovation Initiative, JAMA: Internal Medicine, Journal of Health Economics, Journal of Health Politics, Policy, and Law, Journal of Human Resources, Journal of Law, Economics, and Organization, Journal of Policy Analysis and Management, Journal of Political Economy, Journal of Public Economics, Journal of the European Economic Association, The Milbank Quarterly, New England Journal of Medicine, Preventive Medicine, Quarterly Journal of Economics, RAND Journal of Economics, Review of Economics and Statistics, Science